Therefore, even though osteoblastic-cell-specific activation of Gs-GPCR signaling in our ColI(2.3)+/Rs1+ mouse model increases the Rankl/Opg ratios, the elevated cochlear OPG may be sufficient to spare cochlear bone from the most severe FD lesions. The gene discussed is TNFSF11; the disease is Fabry disease.